| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 3652157
[patent_doc_number] => 05606046
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-02-25
[patent_title] => 'DNA purification by solid phase extraction using trifluorometric acid washed glass fiber membranes'
[patent_app_type] => 1
[patent_app_number] => 8/449585
[patent_app_country] => US
[patent_app_date] => 1995-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4035
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/606/05606046.pdf
[firstpage_image] =>[orig_patent_app_number] => 449585
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/449585 | DNA purification by solid phase extraction using trifluorometric acid washed glass fiber membranes | May 23, 1995 | Issued |
Array
(
[id] => 3700448
[patent_doc_number] => 05677439
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-10-14
[patent_title] => 'Oligonucleotide analogues containing phosphate diester linkage substitutes, compositions thereof, and precursor dinucleotide analogues'
[patent_app_type] => 1
[patent_app_number] => 8/449124
[patent_app_country] => US
[patent_app_date] => 1995-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 17565
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/677/05677439.pdf
[firstpage_image] =>[orig_patent_app_number] => 449124
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/449124 | Oligonucleotide analogues containing phosphate diester linkage substitutes, compositions thereof, and precursor dinucleotide analogues | May 23, 1995 | Issued |
| 08/448836 | 7-DEAZA-2'-DEOXYGUANOSINE NUCLEOTIDES AND USE THEREOF | May 23, 1995 | Abandoned |
Array
(
[id] => 3696333
[patent_doc_number] => 05650506
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-22
[patent_title] => 'Modified glass fiber membranes useful for DNA purification by solid phase extraction'
[patent_app_type] => 1
[patent_app_number] => 8/448711
[patent_app_country] => US
[patent_app_date] => 1995-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4048
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/650/05650506.pdf
[firstpage_image] =>[orig_patent_app_number] => 448711
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/448711 | Modified glass fiber membranes useful for DNA purification by solid phase extraction | May 23, 1995 | Issued |
Array
(
[id] => 3771397
[patent_doc_number] => 05756479
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-26
[patent_title] => 'Flavin adenine dinucleotide analogue inhibitors of monoamine oxidase'
[patent_app_type] => 1
[patent_app_number] => 8/449311
[patent_app_country] => US
[patent_app_date] => 1995-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 11796
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/756/05756479.pdf
[firstpage_image] =>[orig_patent_app_number] => 449311
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/449311 | Flavin adenine dinucleotide analogue inhibitors of monoamine oxidase | May 23, 1995 | Issued |
Array
(
[id] => 3717737
[patent_doc_number] => 05616701
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-04-01
[patent_title] => 'DNA purification by solid phase extraction using a hydroxide-washed glass fiber membrane'
[patent_app_type] => 1
[patent_app_number] => 8/449441
[patent_app_country] => US
[patent_app_date] => 1995-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4034
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/616/05616701.pdf
[firstpage_image] =>[orig_patent_app_number] => 449441
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/449441 | DNA purification by solid phase extraction using a hydroxide-washed glass fiber membrane | May 23, 1995 | Issued |
Array
(
[id] => 3871642
[patent_doc_number] => 05763419
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-09
[patent_title] => 'Treatment of malignant tumors with 8-chloroadenosine 3\',5\'-cyclic monophasphate'
[patent_app_type] => 1
[patent_app_number] => 8/438537
[patent_app_country] => US
[patent_app_date] => 1995-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5070
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/763/05763419.pdf
[firstpage_image] =>[orig_patent_app_number] => 438537
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/438537 | Treatment of malignant tumors with 8-chloroadenosine 3',5'-cyclic monophasphate | May 9, 1995 | Issued |
Array
(
[id] => 3698185
[patent_doc_number] => 05677290
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-10-14
[patent_title] => 'Therapeutic use of adenosine compounds as surgical anesthetics'
[patent_app_type] => 1
[patent_app_number] => 8/437080
[patent_app_country] => US
[patent_app_date] => 1995-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 12
[patent_no_of_words] => 10451
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/677/05677290.pdf
[firstpage_image] =>[orig_patent_app_number] => 437080
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/437080 | Therapeutic use of adenosine compounds as surgical anesthetics | May 4, 1995 | Issued |
| 08/430164 | DERIVATIVES OF CYCLIC GUANOSINE-3',5'-MONOPHOSPHOROTHIOATE | Apr 26, 1995 | Abandoned |
Array
(
[id] => 3620764
[patent_doc_number] => 05614504
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-03-25
[patent_title] => 'Method of making inosine monophosphate derivatives and immunopotentiating uses thereof'
[patent_app_type] => 1
[patent_app_number] => 8/426682
[patent_app_country] => US
[patent_app_date] => 1995-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 19
[patent_no_of_words] => 18096
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/614/05614504.pdf
[firstpage_image] =>[orig_patent_app_number] => 426682
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/426682 | Method of making inosine monophosphate derivatives and immunopotentiating uses thereof | Apr 20, 1995 | Issued |
Array
(
[id] => 3794886
[patent_doc_number] => 05726301
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-03-10
[patent_title] => 'CAC H-phosphonate and its use in the synthesis of oligonucleotides'
[patent_app_type] => 1
[patent_app_number] => 8/415112
[patent_app_country] => US
[patent_app_date] => 1995-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6791
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/726/05726301.pdf
[firstpage_image] =>[orig_patent_app_number] => 415112
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/415112 | CAC H-phosphonate and its use in the synthesis of oligonucleotides | Mar 30, 1995 | Issued |
Array
(
[id] => 3657598
[patent_doc_number] => 05658890
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-08-19
[patent_title] => 'C-nucleoside isostere of nicotinamide adenine dinucleotide, analogs thereof and use as anti-cancer agent'
[patent_app_type] => 1
[patent_app_number] => 8/422065
[patent_app_country] => US
[patent_app_date] => 1995-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 22938
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/658/05658890.pdf
[firstpage_image] =>[orig_patent_app_number] => 422065
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/422065 | C-nucleoside isostere of nicotinamide adenine dinucleotide, analogs thereof and use as anti-cancer agent | Mar 29, 1995 | Issued |
Array
(
[id] => 3652061
[patent_doc_number] => 05606039
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-02-25
[patent_title] => 'Etoposide phosphate and preparative intermediates'
[patent_app_type] => 1
[patent_app_number] => 8/410811
[patent_app_country] => US
[patent_app_date] => 1995-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3787
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/606/05606039.pdf
[firstpage_image] =>[orig_patent_app_number] => 410811
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/410811 | Etoposide phosphate and preparative intermediates | Mar 26, 1995 | Issued |
| 08/409568 | PROCESS FOR THE PREPARATION OF 2,2'-ANHYDRO- AND 2'-KETO-1-(3',5'-DI- O-PROTECTED-BETA-D-ARABINOFURANOSYL)NUCLEOSIDES | Mar 23, 1995 | Abandoned |
Array
(
[id] => 3833022
[patent_doc_number] => 05712258
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-01-27
[patent_title] => 'Inotropic ADP and ATP analogues and their pharmaceutical compositions'
[patent_app_type] => 1
[patent_app_number] => 8/409350
[patent_app_country] => US
[patent_app_date] => 1995-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 13
[patent_no_of_words] => 7786
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/712/05712258.pdf
[firstpage_image] =>[orig_patent_app_number] => 409350
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/409350 | Inotropic ADP and ATP analogues and their pharmaceutical compositions | Mar 22, 1995 | Issued |
Array
(
[id] => 3888761
[patent_doc_number] => 05723599
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-03-03
[patent_title] => 'Organic polymer reagents for solid phase synthesis of oligonucleotides'
[patent_app_type] => 1
[patent_app_number] => 8/409902
[patent_app_country] => US
[patent_app_date] => 1995-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6199
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 241
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/723/05723599.pdf
[firstpage_image] =>[orig_patent_app_number] => 409902
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/409902 | Organic polymer reagents for solid phase synthesis of oligonucleotides | Mar 21, 1995 | Issued |
Array
(
[id] => 3625711
[patent_doc_number] => 05608049
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-03-04
[patent_title] => 'Preparation of d4T from 5-methyluridine'
[patent_app_type] => 1
[patent_app_number] => 8/402283
[patent_app_country] => US
[patent_app_date] => 1995-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3229
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/608/05608049.pdf
[firstpage_image] =>[orig_patent_app_number] => 402283
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/402283 | Preparation of d4T from 5-methyluridine | Mar 9, 1995 | Issued |
Array
(
[id] => 4006831
[patent_doc_number] => 06005093
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-12-21
[patent_title] => 'Non-nucleosidic coumarin derivatives as polynucleotide-crosslinking agents'
[patent_app_type] => 1
[patent_app_number] => 8/401630
[patent_app_country] => US
[patent_app_date] => 1995-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8614
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/005/06005093.pdf
[firstpage_image] =>[orig_patent_app_number] => 401630
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/401630 | Non-nucleosidic coumarin derivatives as polynucleotide-crosslinking agents | Mar 8, 1995 | Issued |
Array
(
[id] => 3770244
[patent_doc_number] => 05849720
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-15
[patent_title] => 'Enhancement of non-specific immune defenses by administration of underivatized, aqueous soluble glucans'
[patent_app_type] => 1
[patent_app_number] => 8/400488
[patent_app_country] => US
[patent_app_date] => 1995-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 4425
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/849/05849720.pdf
[firstpage_image] =>[orig_patent_app_number] => 400488
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/400488 | Enhancement of non-specific immune defenses by administration of underivatized, aqueous soluble glucans | Mar 7, 1995 | Issued |
Array
(
[id] => 4187110
[patent_doc_number] => 06093702
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-07-25
[patent_title] => 'Mixtures of dideoxy-nucleosides and hydroxycarbamide for inhibiting retroviral spread'
[patent_app_type] => 1
[patent_app_number] => 8/401488
[patent_app_country] => US
[patent_app_date] => 1995-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6304
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/093/06093702.pdf
[firstpage_image] =>[orig_patent_app_number] => 401488
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/401488 | Mixtures of dideoxy-nucleosides and hydroxycarbamide for inhibiting retroviral spread | Mar 7, 1995 | Issued |